• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

司库奇尤单抗成功治疗一名患有强直性脊柱炎和家族性地中海热的化脓性汗腺炎患者。

Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever.

作者信息

Unal Enginar Ayse, Gundogdu Mustafa

机构信息

Rheumatology, Ordu State Hospital, Ordu, Turkey.

Dermatology and Venereology, Ordu State Hospital, Ordu, Turkey.

出版信息

Mod Rheumatol Case Rep. 2022 Jan 7;6(1):19-21. doi: 10.1093/mrcr/rxab008.

DOI:10.1093/mrcr/rxab008
PMID:34508267
Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease characterised by pain, inflamed nodules, abscess, sinus tract, and fistula. HS is more common in patients with axial spondyloarthritis and Familial Mediterranean Fever (FMF) compared to the normal population. Mediterranean fever gene mutations are thought to be responsible for the relationship between these three diseases. Case reports of secukinumab treatment in HS have been reported. In this article, a case of successful treatment of HS with secukinumab in a patient with ankylosing spondylitis and FMF is presented.

摘要

化脓性汗腺炎(HS)是一种慢性炎症性疾病,其特征为疼痛、炎性结节、脓肿、窦道和瘘管。与正常人群相比,HS在轴性脊柱关节炎和家族性地中海热(FMF)患者中更为常见。地中海热基因突变被认为是这三种疾病之间关系的原因。已有关于司库奇尤单抗治疗HS的病例报告。本文介绍了一例使用司库奇尤单抗成功治疗患有强直性脊柱炎和FMF的HS患者的病例。

相似文献

1
Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever.司库奇尤单抗成功治疗一名患有强直性脊柱炎和家族性地中海热的化脓性汗腺炎患者。
Mod Rheumatol Case Rep. 2022 Jan 7;6(1):19-21. doi: 10.1093/mrcr/rxab008.
2
Familial Mediterranean fever patients with hidradenitis suppurativa.患有化脓性汗腺炎的家族性地中海热患者。
Int J Dermatol. 2017 Jun;56(6):660-663. doi: 10.1111/ijd.13503. Epub 2017 Feb 14.
3
Association of hidradenitis suppurativa and familial Mediterranean fever: A case series of 6 patients.化脓性汗腺炎与家族性地中海热的关联:6例病例系列报道
Joint Bone Spine. 2017 Mar;84(2):159-162. doi: 10.1016/j.jbspin.2016.02.021. Epub 2016 May 26.
4
Ankylosing Spondylitis Among Familial Mediterranean Fever Patients.家族性地中海热患者中的强直性脊柱炎
Endocr Metab Immune Disord Drug Targets. 2018 Feb 13;18(2):148-154. doi: 10.2174/1871530317666171003155517.
5
Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever.
Rheumatol Int. 2009 Jan;29(3):321-3. doi: 10.1007/s00296-008-0660-2. Epub 2008 Aug 12.
6
Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa.司库奇尤单抗可能是治疗化脓性汗腺炎继发系统性淀粉样变的方法。
Dermatol Ther. 2020 Nov;33(6):e14205. doi: 10.1111/dth.14205. Epub 2020 Sep 11.
7
Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control study.Pyrin 基因突变与自身炎症与复杂性表型化脓性汗腺炎的相关性:一项病例对照研究。
Br J Dermatol. 2019 Jun;180(6):1459-1467. doi: 10.1111/bjd.17466. Epub 2019 Feb 20.
8
High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection.家族性地中海热患者及其一级亲属中脊柱关节炎和强直性脊柱炎的高患病率:两者关联的进一步证据
Arthritis Res Ther. 2013 Jan 28;15(1):R21. doi: 10.1186/ar4154.
9
Ankylosing spondylitis. An unusual manifestation of familial Mediterranean fever. Report of a case complicated by amyloidosis and polyneuropathy.
Clin Rheumatol. 1989 Sep;8(3):408-12. doi: 10.1007/BF02030357.
10
Are there any clinical differences between ankylosing spondylitis patients and familial Mediterranean fever patients with ankylosing spondylitis?强直性脊柱炎患者和伴发强直性脊柱炎的家族性地中海热患者之间存在临床差异吗?
Int J Clin Pract. 2021 Jan;75(1):e13645. doi: 10.1111/ijcp.13645. Epub 2020 Sep 9.

引用本文的文献

1
The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.白细胞介素-17在全身自身炎症性疾病中的作用:机制与治疗前景
Clin Rev Allergy Immunol. 2025 Mar 12;68(1):27. doi: 10.1007/s12016-025-09042-5.
2
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies.化脓性汗腺炎的新兴治疗方法及临床试验概况 第一部分:局部和全身药物治疗
Dermatol Ther (Heidelb). 2023 Aug;13(8):1661-1697. doi: 10.1007/s13555-023-00956-6. Epub 2023 Jul 4.